Appili Therapeutics (TSX: APLI) is a Canadian biopharmaceutical company whose shares trade as a penny stock near the low end of their history, placing it firmly in speculative territory. For risk-tolerant investors, Appili offers an unusual mix of attributes: an FDA-approved commercial product generating …

Aakashdeep | 21 June 2026

Premium

Black Gold Exploration (BGX): The Energy Micro-Cap Testing Investor Patience at Record Lows

Banyan Gold (BYN): The Yukon Gold Stock Attracting Fresh Investor Momentum

Bank of Nova Scotia (BNS): The Dividend Bank Stock Back in the Spotlight Near All-Time Highs

Bank of Montreal (BMO): The Canadian Banking Giant Pushing Into Record-High Territory

Aya Gold & Silver (AYA): The Precious Metals Stock Testing New Highs as Silver Interest Builds

Aurora Solar Technologies (ACU): The Solar Tech Stock Searching for a Turnaround From Record Lows.

Aureum Exploration (AURM): The Micro-Cap Explorer Trying to Build Momentum at Record Levels

Atomic Minerals (ATOM): The Uranium Explorer Sitting Near Record Lows With Speculative Upside

Arras Minerals (ARK): The Exploration Stock Drawing Attention After Reaching Fresh Market Highs

Appili Therapeutics (APLI): The Biotech Penny Stock Investors Are Watching for Recovery Potential

Latest News

AMT - Ameritrust Financial Technologies: The Penny Stock Surge Putting AMT on Canada's Overvalued Watchlist

The TSX Index is expected to open on a positive note

Canadian equities posted modest gains on Thursday

STLR Slides as Gold Explorer Confidence Gets Tested

Why Is Canada Tightening Immigration Fraud Detection? What the New Rules Mean for the Economy and TSX Stocks

Why Is Canada's Parliament Fast-Tracking Key Economic Bills? What It Means for TSX Stocks and Investors